Korean stock Bridge Biotherapeutics rose over 20% today, with a market capitalization reaching approximately 36 million USD.

robot
Abstract generation in progress

On June 20, Bridge Biotherapeutics, Inc., a biotechnology company listed in South Korea, saw its stock price rise by 20.59%, with a market capitalization increasing to 49.218 billion KRW, approximately 36 million USD. Previously, Parataxis Holdings, an investment company focused on the digital asset sector, announced that it has signed a final protocol with Bridge Biotherapeutics, Inc. to invest 25 billion KRW, thereby acquiring a controlling stake in the company ("the Transaction"). After the transaction is completed, the company plans to change its name to Parataxis Korea and continue to be listed on KOSDAQ.

View Original
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)